UBS cuts Carter’s stock price target to $33 on soft sales outlook
UBS reduced Carter’s (CRI) price target to $33 from $38, citing softer sales outlook despite strong profitability. Carter’s Q3 2026 earnings beat expectations with $1.03 EPS and $752.46M revenue, but management lowered its outlook for U.S. Retail and Wholesale segments. The company trades at a P/E ratio of 5.88 with a 27% free cash flow yield.
How this was made
The 30-second read
Why it matters
Analyst target reductions are a fresh catalyst that can move the stock lower despite the earnings beat.
Market read
Analyst target cuts after earnings provide a near‑term bearish signal for CRI.
What to watch
Management's brand repositioning initiatives may unlock longer‑term growth not reflected in the short‑term target cuts.
Background
Carter's reported Q3 2026 earnings that beat estimates, but guidance was softened, prompting analyst target reductions.
Ticker impact
UBS and BofA cut price targets for Carter's after its Q3 earnings beat, indicating softer outlook and potential downside.
downward pressure as investors digest lower targets and cautious outlook
Both UBS and BofA lowered targets on the same day of the earnings release, a clear fresh catalyst for short-term weakness.
Market effects
Retail sector may see broader scrutiny as softer demand signals could affect peers.
U.S. consumer discretionary stocks could face pressure in the near term.
Limited to U.S. markets; no immediate global ripple.
Counterpoint
Despite target cuts, the earnings beat and strong cash flow yield could support a bounce if the market overreacts.
Key entities
- companyCarter's Inc.
U.S. retailer reporting Q3 earnings and receiving analyst target cuts.
- analyst_firmUBS
Reduced price target to $33, maintaining Neutral rating.
- analyst_firmBofA Securities
Lowered price target to $28, maintaining Underperform rating.
